Welcome to our dedicated page for Smartkem SEC filings (Ticker: SMTK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
SmartKem, Inc. filings document the public-company record for an organic semiconductor technology developer with common stock listed on Nasdaq under SMTK. The filings cover material-event reports, Securities Act registration statements, notices about annual-report timing, and disclosures tied to its advanced-materials and transistor-backplane business.
Recent regulatory documents address material definitive agreements, convertible notes, preferred stock financings, warrants, private placements, resale registration matters, Nasdaq listing-compliance disclosures, officer and subsidiary governance changes, shareholder voting matters, operating and financial results, and capital-structure updates involving common stock, preferred stock, and warrant securities.
SmartKem, Inc. (SMTK) Form 4 shows Ian Jenks, Chairman & CEO and Director, was granted a stock option on 09/03/2025 to acquire 160,005 shares of Common Stock at an exercise price of $1.16 per share. The option vests 25% on the grant date with the remaining shares vesting in equal monthly installments over 36 months beginning September 3, 2025. The option is exercisable through 09/03/2035. The Form 4 was signed by Ian Jenks on 09/05/2025.
Insider grant and holdings summary: SmartKem CFO Barbra Keck was granted a stock option on 09/03/2025 giving the right to buy 71,077 shares of common stock at an exercise price of $1.16 per share. The option is exercisable through 09/03/2035. Following the grant, Keck beneficially owns 71,077 underlying shares, held directly. The option vests 25% at grant with the remainder vesting in equal monthly installments over 36 months beginning 09/03/2025, with monthly vesting on the 3rd.
Peruvemba Sriram Krishnamurthy, a director of SmartKem, Inc. (SMTK), was granted a stock option on 09/03/2025 for the right to buy 22,466 shares of Common Stock at an exercise price of $1.16 per share. The option was acquired and is exercisable under a schedule that vests 25% on the grant date with the remaining shares vesting in equal monthly installments over 36 months beginning September 3, 2025. The option expires on September 3, 2035. Following the reported transaction the reporting person directly beneficially owns 22,466 option shares. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 09/05/2025.
SmartKem, Inc. reported new equity awards and a change to its CEO’s employment terms. On September 3, 2025, the board’s Compensation Committee granted stock options at an exercise price of $1.16 per share to the CEO, CFO and four non-employee directors, vesting 25% immediately and the rest monthly over 36 months from October 3, 2025.
The company also amended CEO Ian Jenks’s employment agreement, increasing his cash severance from six to twelve months of base salary if he is terminated without Cause or resigns for Good Reason. As of September 5, 2025, SmartKem had 5,479,787 common shares outstanding.
SmartKem, Inc. filed a current report stating that on August 28, 2025 it issued a press release announcing that it intends to consider and pursue strategic alternatives. This typically means the company is formally exploring options to change or enhance its business or capital structure, which can include a wide range of potential actions described in the press release itself.
The company’s common stock continues to trade on The Nasdaq Stock Market under the symbol SMTK. The press release describing these plans is furnished as Exhibit 99.1 to the report and incorporated by reference.
SmartKem, Inc. reports that Nasdaq has notified the company it is not meeting the Nasdaq Capital Market’s minimum stockholders’ equity requirement. The notice cites a stockholders’ deficit of ($127,000) in SmartKem’s Form 10-Q for the period ended June 30, 2025, below the required minimum equity of $2.5 million, and notes that the company also does not meet alternative standards based on market value or net income.
The company’s shares remain listed on Nasdaq for now while it works to regain compliance. SmartKem has until September 29, 2025 to submit a compliance plan, and Nasdaq may grant an extension to as late as February 11, 2026. SmartKem plans to submit a plan but warns there is no assurance Nasdaq will accept it or that it will be able to regain or maintain compliance.
SmartKem ownership disclosure: Bleichroeder LP, Bleichroeder Holdings LLC and Andrew Gundlach report beneficial ownership of 231,666 common shares of SmartKem, representing 5.04% of the class. The filing shows the reporting parties hold sole voting and sole dispositive power over those shares and report no shared voting or dispositive power.
The filing notes that Bleichroeder LP is an investment adviser acting for various clients who retain the right to receive dividends or sale proceeds. The statement includes a certification that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.
Form 8-K filing dated 9 July 2025 reports a single material event under Item 8.01. SmartKem, Inc. (Nasdaq: SMTK) states that it has signed a preliminary joint development agreement with Manz Asia. No financial terms, timelines, or performance commitments are disclosed in the filing.
The company furnished Exhibit 99.1, a press release announcing the agreement, and an iXBRL cover page file (Exhibit 104). There are no accompanying financial statements, guidance changes, or pro-forma data; the report is informational only.
The filing confirms SmartKem remains an emerging growth company and maintains its listing of common shares (symbol SMTK) on The Nasdaq Stock Market. All other sections—Items 1 through 7—are omitted, indicating no additional material developments.
On 19 June 2025, SmartKem Limited, a wholly owned subsidiary of SmartKem, Inc. (Nasdaq: SMTK), signed a Letter of Variation with CPI Innovation Services Limited (CPIIS). The document amends the Framework Services Agreement originally dated 22 March 2024 and most recently due to expire on 30 June 2025.
- Term extension: The services arrangement is now extended to 31 December 2025, unless a separate licence agreement between the parties begins sooner.
- Scope of services: SmartKem continues to purchase access to CPI’s process-fabrication equipment and specialised staff, which are central to the company’s flexible semiconductor R&D and prototyping work.
- Cost provisions: CPIIS agreed to waive SmartKem’s minimum usage obligations during the extension period, potentially lowering fixed operating costs. SmartKem will, however, share certain relocation expenses tied to CPIIS’s facility consolidation.
- Automatic termination: The amended agreement will end on the earlier of (i) commencement of a licence agreement or (ii) 31 December 2025.
- The Letter of Variation is filed as Exhibit 10.1; portions have been omitted as non-material and confidential.
No financial statements, revenue figures, or earnings guidance were included in this Form 8-K.